Home Cart Sign in  
Chemical Structure| 330600-85-6 Chemical Structure| 330600-85-6

Structure of Peramivir
CAS No.: 330600-85-6

Chemical Structure| 330600-85-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Peramivir is a transition-state analogue and a potent, specific influenza viral neuraminidase inhibitor with an IC50 of median 0.09 nM.

Synonyms: BCX-1812; RWJ-270201

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Peramivir

CAS No. :330600-85-6
Formula : C15H28N4O4
M.W : 328.41
SMILES Code : O=C([C@@H]1[C@@H](O)[C@@H]([C@@H](NC(C)=O)C(CC)CC)[C@H](NC(N)=N)C1)O
Synonyms :
BCX-1812; RWJ-270201
MDL No. :MFCD09837902
InChI Key :XRQDFNLINLXZLB-CKIKVBCHSA-N
Pubchem ID :154234

Safety of Peramivir

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03684044 Influenza Phase 3 Recruiting July 10, 2021 -
NCT01055990 Virus Diseases ... More >> Respiratory Tract Diseases Respiratory Tract Infections Influenza Orthomyxoviridae Infections Less << Phase 2 Unknown May 2010 China, Shanghai ... More >> Shanghai Public Health Clinical Center Shanghai, Shanghai, China, 201508 Less <<
NCT02609399 - Active, not recruiting - -
NCT00297050 Influenza Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00453999 Influenza Phase 2 Completed - -
NCT00419263 - Completed - -
NCT00453999 - Completed - -
NCT00705406 Acute, Uncomplicated Human Inf... More >>luenza Less << Phase 2 Completed - -
NCT02609399 Influenza Phase 4 Active, not recruiting August 21, 2019 United States, Arizona ... More >> Maricopa Integrated Health System Phoenix, Arizona, United States, 85008 United States, Maryland Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 Less <<
NCT01146353 - Withdrawn(Peramivir EUA termin... More >>ated by FDA.) Less << - United States, Illinois ... More >> Midwestern University/Northwestern Memorial Hospital Chicago, Illinois, United States, 60611 Less <<
NCT00419263 Influenza Phase 2 Completed - -
NCT00486980 Influenza Phase 3 Withdrawn(This study was withd... More >>rawn for administrative reasons. The dose ranging plan for the program was revised".) Less << - -
NCT00610935 Influenza Phase 3 Terminated(This study was term... More >>inated for administrative reasons.) Less << - -
NCT00705406 - Completed - -
NCT00958776 Cough Sore Th... More >>roat Nasal Congestion Headache Fever Seasonal Influenza Less << Phase 3 Terminated(This study was term... More >>inated for futility) Less << - -
NCT00958776 - Terminated(This study was term... More >>inated for futility) Less << - -
NCT00957996 - Completed - -
NCT01063933 Influenza Phase 1 Phase 2 Withdrawn December 2012 -
NCT02369159 Influenza Phase 3 Recruiting December 2019 United States, Louisiana ... More >> Peramivir Investigative Site Withdrawn New Orleans, Louisiana, United States Peramivir Investigative Site Recruiting Shreveport, Louisiana, United States United States, Michigan Peramivir Investigative Site Recruiting Troy, Michigan, United States United States, Ohio Peramivir investigative site Recruiting Dayton, Ohio, United States United States, Pennsylvania Peramivir investigative site Recruiting Smithfield, Pennsylvania, United States United States, Tennessee Peramivir Investigative Site Withdrawn Nashville, Tennessee, United States United States, Texas Peramivir Investigative Site Recruiting Houston, Texas, United States Peramivir investigative site Completed San Antonio, Texas, United States Peramivir investigative site Recruiting Splendora, Texas, United States Peramivir investigative site Withdrawn Tidwell, Texas, United States United States, Utah Peramivir investigative site Recruiting Draper, Utah, United States Peramivir investigative site Recruiting Salt Lake City, Utah, United States Peramivir investigative site Recruiting South Jordan, Utah, United States Less <<
NCT02635724 Influenza Phase 3 Completed - United States, Florida ... More >> Peramivir Investigational Site Brooksville, Florida, United States Peramivir Investigational Site Lakeland, Florida, United States Peramivir Investigational Site Miami, Florida, United States Peramivir Investigational Site Saint Petersburg, Florida, United States Peramivir Investigational Site Tampa, Florida, United States United States, Indiana Peramivir investigative site Indianapolis, Indiana, United States United States, Michigan Peramivir investigative site Detroit, Michigan, United States United States, Ohio Peramivir Investigational Site Dayton, Ohio, United States United States, Pennsylvania Peramivir investigative site Smithfield, Pennsylvania, United States United States, Texas Peramivir Investigational Site Houston, Texas, United States Peramivir Investigative Site San Antonio, Texas, United States Peramivir investigative site Splendora, Texas, United States United States, Utah Peramivir Investigational Site Draper, Utah, United States Peramivir Investigational Site Salt Lake City, Utah, United States Peramivir investigative site South Jordan, Utah, United States Less <<
NCT01224795 Influenza Phase 3 Terminated(This study was term... More >>inated for administrative reasons) Less << - -
NCT02665351 Influenza Phase 2 Phase 3 Completed - China, Hong Kong ... More >> Prince of Wales Hospital Hong Kong, Hong Kong, China Less <<
NCT00957996 Seasonal Influenza ... More >> Cough Sore Throat Nasal Congestion Myalgia Headache Fatigue Less << Phase 3 Completed - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.04mL

0.61mL

0.30mL

15.22mL

3.04mL

1.52mL

30.45mL

6.09mL

3.04mL

References

 

Historical Records

Categories